Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome

Conclusions: AIMF contributes to cytopenias in the subset of patients with various autoimmune disorders. The majority of patients with AIMF experience an improvement in cytopenias with immunosuppressive therapy.Acta Haematol 2017;138:129-137
Source: Acta Haematologica - Category: Hematology Source Type: research